Literature DB >> 29339210

The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.

Danlu Jiang1, Sheng Chen1, Ruyu Sun1, Xue Zhang2, Di Wang3.   

Abstract

Inflammasomes are large multimolecular complexes present in the cytosol of stimulated immune cells; they mediate the activation of caspase-1, leading to cellular pyroptosis. So far, a variety of studies on inflammasomes have emerged, and the best-studied is the NLRP3 inflammasome that is involved in many inflammatory responses. Furthermore, its relationship with metabolism is gaining increasing attention in this field. In this review, we discuss the importance of the NLRP3 inflammasome in metabolic disorders and its close association with metabolic pathways.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-18; IL-1β; Metabolic disorder; Metabolic pathway; NLRP3 inflammasome

Mesh:

Substances:

Year:  2018        PMID: 29339210     DOI: 10.1016/j.canlet.2018.01.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  33 in total

Review 1.  NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases.

Authors:  Jin Wang; Simeng Chen; Min Liu; Min Zhang; Xiaoyi Jia
Journal:  Inflammopharmacology       Date:  2022-07-13       Impact factor: 5.093

2.  Myeloid atg5 deletion impairs n-3 PUFA-mediated atheroprotection.

Authors:  Zhan Wang; Russel C Sequeira; Manal Zabalawi; Jennifer Madenspacher; Elena Boudyguina; Tiantong Ou; Jonathan M Nelson; Yan Nie; Qingxia Zhao; Michael B Fessler; Xuewei Zhu
Journal:  Atherosclerosis       Date:  2020-01-12       Impact factor: 5.162

3.  NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water.

Authors:  Liu-Yan Zhu; Chang Liu; Zong-Rui Li; Chen Niu; Jian Wu
Journal:  Lab Invest       Date:  2021-02-01       Impact factor: 5.662

Review 4.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 5.  Complement and human T cell metabolism: Location, location, location.

Authors:  Erin E West; Natalia Kunz; Claudia Kemper
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 10.983

6.  Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice.

Authors:  Yunxia Fan; Liwu Du; Qun Fu; Zhiqiang Zhou; Jingyu Zhang; Guomin Li; Jing Wu
Journal:  Front Cell Neurosci       Date:  2018-11-19       Impact factor: 5.505

Review 7.  Inflammatory signaling mechanisms in bipolar disorder.

Authors:  Gregory H Jones; Courtney M Vecera; Omar F Pinjari; Rodrigo Machado-Vieira
Journal:  J Biomed Sci       Date:  2021-06-11       Impact factor: 8.410

8.  Screening-based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming.

Authors:  Wenyu Cui; Sheng Chen; Zhexu Chi; Xingchen Guo; Xiaobo Zhang; Yueyang Zhong; Haijie Han; Ke Yao
Journal:  Clin Transl Med       Date:  2021-07

9.  Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages.

Authors:  Qiu-Yan Liu; Yu Zhuang; Xian-Rui Song; Qun Niu; Qiu-Shuang Sun; Xiao-Nan Li; Ning Li; Bao-Lin Liu; Fang Huang; Zhi-Xia Qiu
Journal:  Acta Pharmacol Sin       Date:  2020-10-07       Impact factor: 7.169

10.  Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats.

Authors:  Taiyang Liao; Liang Ding; Peng Wu; Li Zhang; Xiaochen Li; Bo Xu; Haosheng Zhang; Zhenyuan Ma; Yancheng Xiao; Peimin Wang
Journal:  Drug Des Devel Ther       Date:  2020-07-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.